NovoRapid Penfill 100IU/mL is a fast-acting insulin analog containing insulin aspart, specifically engineered to mimic the body’s natural insulin response after meals. Supplied in a prefilled 3 mL cartridge format, it is designed for use exclusively with compatible reusable insulin pens. NovoRapid delivers rapid onset and short duration of action, making it a preferred choice for mealtime glucose control in individuals with diabetes.

- Diabetes > Type 1 & Type 2 Diabetes - Mealtime Insulin Therapy NovoRapid Penfill is indicated for adults, adolescents, and children aged 1 year and above with Type 1 or Type 2 diabetes requiring rapid-acting insulin. Administered just before or soon after meals, it helps control postprandial blood glucose spikes. When used as part of a basal-bolus regimen, it offers tight glucose control with flexibility and rapid absorption.

- Active Ingredient: Insulin Aspart 100IU/mL - Rapid onset (within 10–20 minutes), peak action at 1–3 hours, duration up to 5 hours - Suitable for subcutaneous injection in the abdomen, thigh, or upper arm - Must be used with a compatible reusable insulin pen (e.g., NovoPen series) - Stable blood sugar management during meals with reduced risk of post-meal hyperglycemia - Clear solution, free from clouding or precipitation

- Administer immediately before or within 20 minutes after starting a meal - Use a compatible pen device to insert the cartridge securely - Always prime the pen before injection to ensure full insulin delivery - Injection sites should be rotated to avoid lipodystrophy - Store opened cartridges at room temperature (below 25°C) for up to 4 weeks; unopened cartridges should be refrigerated (2–8°C) - Avoid exposure to direct sunlight or freezing temperatures - Do not reuse needles; discard properly after each injection

Unopened cartridges: Store in a refrigerator between 2°C to 8°C. In-use cartridge: Store below 25°C and use within 4 weeks. Do not freeze. Keep away from direct light. Do not store with the needle attached.

- Hypoglycemia due to improper timing or overdosage - Injection site reactions such as redness, swelling, or itching - Lipohypertrophy from repeated use of the same injection site - Risk of infection if the needle is reused or not handled hygienically - Cartridge damage or insulin degradation if not stored properly